Search

everythinglearnresearchcommunity

for

Search:↓

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

A patient's grey hair regained color during treatment with adalimumab.

Some systemic treatments work for nail psoriasis but can have serious side effects.

Membership in a self-help organization is linked to being better informed and having a higher education, but it doesn't clearly affect disease outcomes.

A woman's rare scalp condition worsened after using a specific arthritis medication, suggesting such medications can sometimes trigger or aggravate psoriasis.

Patients need better information about the risks of long-term steroid use.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Some drugs used to treat inflammation may cause hair loss.

A girl with Crohn's disease developed hair loss due to her increased medication, a rare side effect seen in some children.

Certain drugs can cause hair loss, but stopping the drug usually leads to hair regrowth.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

The model and estimator can predict drug exposure in kidney transplant patients well.

Some medications might reverse gray hair, especially those that reduce inflammation or stimulate pigment production, and vitamin B might help.

Paternal drug exposure can harm fertility, pregnancy outcomes, and offspring health, with specific drugs linked to various reproductive issues.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

TNF-alpha inhibitors can cause various immune-related skin issues.

Recent findings suggest that genetic factors, immune system issues, and skin cell defects might contribute to the development of hidradenitis suppurativa.

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.

The study found key factors in the cause of hidradenitis suppurativa, its link to other diseases, and identified existing drugs that could potentially treat it.

Personalized thiopurine dosing based on NUDT15 genotyping can improve long-term outcomes for ulcerative colitis and Crohn's disease patients.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

Methotrexate is not proven to maintain remission in ulcerative colitis.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

There is no standardized treatment for hidradenitis suppurativa, and individualized plans are needed.

Social media can help compare the effectiveness and safety of new arthritis medications.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.